23 septembre 2021 Catégories Les recherches en cours Tags *recherche* https://www.fiercebiotech.com/biotech/novartis-optogenetics-arctor-vedere-gene-therapy-eye-disease-blindness Novartis doesn’t think optogenetics will completely cure blindness—but its new biotech is going to give it a try Source Facebook Articles en relation2 août 2022Tageslicht zurück ins Blickfeld holen: Forschende transplantieren menschliche Photorezeptoren, um die Wahrnehmung von Tageslicht bei Mäusen wiederherzustellenEn savoir plus17 mai 20224D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates | 4D Molecular TherapeuticsEn savoir plus19 mars 2022FDA-Approved Drug May Help Revive Vision in People With Progressive Blinding DisordersEn savoir plus
